Archive | BIOTRONIK

BIOTRONIK - Archive

2020
15
November
2020
| 17:56 Europe/Amsterdam
 In their short time on the market, bioresorbable vascular scaffolds have generated plenty of discussion within interventional cardiology. According to the authors of “Fading Away or Hope for the Future,” published by the American College of Cardiolo...
Read more
29
October
2020
| 18:07 Europe/Amsterdam
About one in four people globally will have a stroke in their lifetimes. Stroke is the fifth-leading cause of death in the US and accounts for over a million deaths in Europe every year. The most common heart rhythm disorder—atrial fibrillation (AF)—...
Read more
01
October
2020
| 12:49 Europe/Amsterdam
  As we get older, our risk for a variety of cardiovascular conditions increases. It’s a fact that likely doesn’t come as a big surprise to many people—but that doesn’t mean the discussions aging patients need to have with their families and docto...
Read more
29
September
2020
| 08:26 Europe/Amsterdam
Walking about eight kilometres over the course of a week, at an average pace (3 km per hour), cuts the risk of cardiovascular events by almost a third. ...
Read more
17
September
2020
| 08:57 Europe/Amsterdam
Outcomes of the BIO4AMB trial presented at the CIRSE 2020 Summit demonstrated that ambulatory treatment with 4­‑French (4F) devices is a valid and safe option for endovascular treatment of lower extremity peripheral artery disease (PAD). The 4F compa...
Read more
07
September
2020
| 08:45 Europe/Amsterdam
BIOTRONIK today announced European market release of the Passeo®‑35 Xeo PTA (percutaneous transluminal angioplasty) balloon catheter. Compared to other available PTA balloons1, the device offers physicians improved crossability, excellent trackabilit...
Read more
01
September
2020
| 16:12 Europe/Amsterdam
A new study1 presented at this year’s European Society of Cardiology (ESC) Congress today shows that BIOTRONIK’s exclusive Closed Loop Stimulation (CLS) helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. ...
Read more
01
September
2020
| 07:00 Europe/Amsterdam
Cardiologists balancing increasing workload pressures and time demands in their clinics, have from today access to a new injectable cardiac monitor (ICM). BIOMONITOR IIIm is equipped with a unique algorithm that significantly reduces false positive a...
Read more
24
August
2020
| 13:06 Europe/Amsterdam
Almost 30 years after the US FDA rescinded a ban on women of “childbearing potential” from participating in clinical studies, women remain underrepresented in many key areas for medical trials—including cardiovascular medicine. This is despite guidan...
Read more
17
August
2020
| 13:35 Europe/Amsterdam
Remote monitoring - when managed appropriately - has always had the potential to streamline workflows for cardiac device specialists and their staffs. The ongoing COVID-19 pandemic however, has made the transition to more remote-based follow-up parti...
Read more
29
July
2020
| 16:24 Europe/Amsterdam
Long after the COVID-19 public health crisis is solved, whether through medicine, vaccination or other developments, our current pandemic moment may well be depicted in future medical textbooks as the moment we got over our lingering skepticism of di...
Read more
22
July
2020
| 17:54 Europe/Amsterdam
The true toll COVID-19 has taken on public health around the world is difficult to pinpoint at the moment - but it’s much higher than the official death toll from the virus itself. ...
Read more
14
July
2020
| 09:55 Europe/Amsterdam
BIOTRONIK is proud to announce the availability of its next-generation balloon-expandable cobalt chromium iliac stent system, Dynetic®-35. When compared to leading competitors, the new peripheral stent has up to 14 times greater flexibility and up to...
Read more
08
July
2020
| 16:59 Europe/Amsterdam
This year will long be remembered as the year the COVID-19 pandemic overwhelmed healthcare systems around the world. From postponing elective surgeries to reassigning entire hospital units to coronavirus response, hospitals have gone to unprecedented...
Read more
01
July
2020
| 14:00 Europe/Amsterdam
A major challenge in most specialties of medicine involves moving from vague, diffuse symptoms to accurate diagnosis. This can be particularly challenging in cardiology. ...
Read more
19
June
2020
| 20:50 Europe/Amsterdam
CardioMessenger devices form an essential part of BIOTRONIK’s remote monitoring system, enabling the secure transmission of critical patient and device data to the treating physician. As the company that pioneered remote monitoring, we have taken cyb...
Read more
16
June
2020
| 12:50 Europe/Amsterdam
BIOTRONIK has today announced its commitment to giving physicians additional tools to pace in the His-Bundle, coinciding with the launch of its His-Bundle Pacing (HBP) tools in a limited number of centers starting now with a full launch later in 2020...
Read more
20
May
2020
| 16:00 Europe/Amsterdam
BIOTRONIK and Acutus Medical today announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment of cardiac arrhythmias across select markets, including Europ...
Read more
13
May
2020
| 13:30 Europe/Amsterdam
Results just published in Circulation Arrhythmia and Electrophysiology confirm that BIOTRONIK Home Monitoring® provides safe and cost-effective remote management of pacemaker patients,1 indicating that it can safely replace the common practice of rou...
Read more
06
May
2020
| 09:24 Europe/Amsterdam
According to recently presented TICO trial data, patients with acute coronary syndrome (ACS) treated with BIOTRONIK’s Orsiro® drug eluting stent (DES) benefit from stopping aspirin three months after stenting and continuing only with ticagrelor monot...
Read more
31
March
2020
| 10:18 Europe/Amsterdam
As the COVID-19 pandemic continues, we are conscious of the enormous strain that you are all under. We share your concerns about the spread of the virus and the disruption it is causing globally. We are doing what we can to help minimize this disrupt...
Read more
04
March
2020
| 14:02 Europe/Amsterdam
The US Food and Drug Administration has issued a Safety Communication regarding a family of cybersecurity vulnerabilities known as SweynTooth, which may introduce risks for certain medical devices that use Bluetooth Low Energy (BLE) wireless communic...
Read more
24
February
2020
| 00:00 Europe/Amsterdam
BIOTRONIK today announced three-year data from the BIOFLOW-V trial, which was presented yesterday at the 2020 CRT Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinfo...
Read more
21
February
2020
| 14:11 Europe/Amsterdam
BIOTRONIK has announced CE Mark certification for the Orsiro® Mission drug-eluting stent (DES) system. The next generation of the company’s ultrathin strut Orsiro DES provides higher deliverability than other contemporary stents.1 Orsiro Mission is n...
Read more
27
January
2020
| 00:00 Europe/Amsterdam
BIOTRONIK, Inc. today announced the appointment of David Hayes, MD, FACC, as Chief Medical Officer. Dr. Hayes will oversee the development of BIOTRONIK’s cardiovascular solutions with a focus on advancing unique, proven innovations that help physicia...
Read more
23
January
2020
| 00:00 Europe/Amsterdam
BIOTRONIK this month announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III. The novel device is designed to help patients with irregular heart rhythms by documenting unexplained syncope with increased clarity. As...
Read more
2019
18
December
2019
| 14:29 Europe/Amsterdam
  Medtech companies operating in Europe are getting ready for a busy year, with the end of the transition period for the European Union’s Medical Device Regulation (MDR) fast approaching. After the May 2020 deadline, all new medical devices must m...
Read more
30
October
2019
| 00:00 Europe/Amsterdam
BIOTRONIK announced today that its Orsiro® coronary drug-eluting stent (DES) has been approved for sale in China by the National Medical Products Administration. The company expects to make the device available to Chinese patients and physicians in t...
Read more
18
October
2019
| 14:54 Europe/Amsterdam
  About 30 percent of patients undergoing primary percutaneous coronary intervention (PCI) suffer from ST-Elevation Myocardial Infarction (STEMI) – the most acute form of coronary artery disease. It’s caused by a complete thrombotic occlusion and ...
Read more
04
October
2019
| 15:31 Europe/Amsterdam
On October 1, the US Food and Drug Administration (FDA) issued a Safety Communication regarding a set of cybersecurity vulnerabilities, referred to as “Urgent/11” that — if exploited by a remote attacker — may introduce risks for medical devices and ...
Read more